Human endogenous peptide p33 inhibits detrimental effects of LL-37 on osteoblast viability.

Daniel Svensson, Johannes Westman, Claes Wickström, Daniel Jönsson, Heiko Herwald, Bengt-Olof Nilsson

Research output: Contribution to journalArticlepeer-review

10 Citations (SciVal)

Abstract

High levels of the antimicrobial peptide, LL-37, are detected in gingival crevicular fluid from patients with chronic periodontitis. LL-37 not only shows antimicrobial activity but also affects host-cell viability. The objective of the present study was to identify endogenous mechanisms that antagonize the detrimental effects of LL-37 on osteoblast viability, focusing on the human peptide p33 expressed on the surface of various cell types.
Original languageEnglish
Pages (from-to)80-88
JournalJournal of Periodontal Research
Volume50
Issue number1
DOIs
Publication statusPublished - 2015

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Vascular Physiology (013212034), Mucosal biology (013212033), Division of Infection Medicine (BMC) (013024020)

Subject classification (UKÄ)

  • Dentistry

Fingerprint

Dive into the research topics of 'Human endogenous peptide p33 inhibits detrimental effects of LL-37 on osteoblast viability.'. Together they form a unique fingerprint.

Cite this